These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 36882837)

  • 1. Exercise activates Sirt1-mediated Drp1 acetylation and inhibits hepatocyte apoptosis to improve nonalcoholic fatty liver disease.
    Hu Z; Zhang H; Wang Y; Li B; Liu K; Ran J; Li L
    Lipids Health Dis; 2023 Mar; 22(1):33. PubMed ID: 36882837
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elucidation of SIRT-1/PGC-1α-associated mitochondrial dysfunction and autophagy in nonalcoholic fatty liver disease.
    Jiang Y; Chen D; Gong Q; Xu Q; Pan D; Lu F; Tang Q
    Lipids Health Dis; 2021 Apr; 20(1):40. PubMed ID: 33902605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antrodia cinnamomea and its compound dehydroeburicoic acid attenuate nonalcoholic fatty liver disease by upregulating ALDH2 activity.
    Cao YN; Yue SS; Wang AY; Xu L; Hu YT; Qiao X; Wu TY; Ye M; Wu YC; Qi R
    J Ethnopharmacol; 2022 Jun; 292():115146. PubMed ID: 35304272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitochondrial dysfunction in high-fat diet-induced nonalcoholic fatty liver disease: The alleviating effect and its mechanism of Polygonatum kingianum.
    Yang XX; Wang X; Shi TT; Dong JC; Li FJ; Zeng LX; Yang M; Gu W; Li JP; Yu J
    Biomed Pharmacother; 2019 Sep; 117():109083. PubMed ID: 31387169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exercise intervention improves mitochondrial quality in non-alcoholic fatty liver disease zebrafish.
    Zou YY; Tang XB; Chen ZL; Liu B; Zheng L; Song MY; Xiao Q; Zhou ZQ; Peng XY; Tang CF
    Front Endocrinol (Lausanne); 2023; 14():1162485. PubMed ID: 37284220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. G protein-coupled receptor 39 alleviates mitochondrial dysfunction and hepatocyte lipid accumulation via SIRT1/Nrf2 signaling.
    Chen Q; Lou Y
    J Bioenerg Biomembr; 2023 Feb; 55(1):33-42. PubMed ID: 36525212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of hepassocin in the development of non-alcoholic fatty liver disease.
    Wu HT; Lu FH; Ou HY; Su YC; Hung HC; Wu JS; Yang YC; Wu CL; Chang CJ
    J Hepatol; 2013 Nov; 59(5):1065-72. PubMed ID: 23792031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CircLDLR acts as a sponge for miR-667-5p to regulate SIRT1 expression in non-alcoholic fatty liver disease.
    Yuan X; Li Y; Wen S; Xu C; Wang C; He Y; Zhou L
    Lipids Health Dis; 2022 Nov; 21(1):127. PubMed ID: 36443854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psoralea corylifolia L. extract ameliorates nonalcoholic fatty liver disease in free-fatty-acid-incubated HEPG2 cells and in high-fat diet-fed mice.
    Hong Y; Choi SI; Hong E; Kim GH
    J Food Sci; 2020 Jul; 85(7):2216-2226. PubMed ID: 32579753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alpha-naphthoflavone attenuates non-alcoholic fatty liver disease in oleic acid-treated HepG2 hepatocytes and in high fat diet-fed mice.
    Xia H; Zhu X; Zhang X; Jiang H; Li B; Wang Z; Li D; Jin Y
    Biomed Pharmacother; 2019 Oct; 118():109287. PubMed ID: 31401392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Asiatic acid from Potentilla chinensis alleviates non-alcoholic fatty liver by regulating endoplasmic reticulum stress and lipid metabolism.
    Wang D; Lao L; Pang X; Qiao Q; Pang L; Feng Z; Bai F; Sun X; Lin X; Wei J
    Int Immunopharmacol; 2018 Dec; 65():256-267. PubMed ID: 30340105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-122 promotes hepatic lipogenesis via inhibiting the LKB1/AMPK pathway by targeting Sirt1 in non-alcoholic fatty liver disease.
    Long JK; Dai W; Zheng YW; Zhao SP
    Mol Med; 2019 Jun; 25(1):26. PubMed ID: 31195981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased Drp1 Acetylation by Lipid Overload Induces Cardiomyocyte Death and Heart Dysfunction.
    Hu Q; Zhang H; Gutiérrez Cortés N; Wu D; Wang P; Zhang J; Mattison JA; Smith E; Bettcher LF; Wang M; Lakatta EG; Sheu SS; Wang W
    Circ Res; 2020 Feb; 126(4):456-470. PubMed ID: 31896304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dihydromyricetin Ameliorates Nonalcoholic Fatty Liver Disease by Improving Mitochondrial Respiratory Capacity and Redox Homeostasis Through Modulation of SIRT3 Signaling.
    Zeng X; Yang J; Hu O; Huang J; Ran L; Chen M; Zhang Y; Zhou X; Zhu J; Zhang Q; Yi L; Mi M
    Antioxid Redox Signal; 2019 Jan; 30(2):163-183. PubMed ID: 29310441
    [No Abstract]   [Full Text] [Related]  

  • 15. Atractylenolide III ameliorates Non-Alcoholic Fatty Liver Disease by activating Hepatic Adiponectin Receptor 1-Mediated AMPK Pathway.
    Li Q; Tan JX; He Y; Bai F; Li SW; Hou YW; Ji LS; Gao YT; Zhang X; Zhou ZH; Yu Z; Fang M; Gao YQ; Li M
    Int J Biol Sci; 2022; 18(4):1594-1611. PubMed ID: 35280674
    [No Abstract]   [Full Text] [Related]  

  • 16. Oleic acid protects saturated fatty acid mediated lipotoxicity in hepatocytes and rat of non-alcoholic steatohepatitis.
    Chen X; Li L; Liu X; Luo R; Liao G; Li L; Liu J; Cheng J; Lu Y; Chen Y
    Life Sci; 2018 Jun; 203():291-304. PubMed ID: 29709653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plant sterol ester of α-linolenic acid ameliorates high-fat diet-induced nonalcoholic fatty liver disease in mice: association with regulating mitochondrial dysfunction and oxidative stress via activating AMPK signaling.
    Han H; Li X; Guo Y; Zheng M; Xue T; Wang L
    Food Funct; 2021 Mar; 12(5):2171-2188. PubMed ID: 33566044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-34a regulates lipid metabolism by targeting SIRT1 in non-alcoholic fatty liver disease with iron overload.
    Wang L; Sun M; Cao Y; Ma L; Shen Y; Velikanova AA; Li X; Sun C; Zhao Y
    Arch Biochem Biophys; 2020 Nov; 695():108642. PubMed ID: 33098868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-205 ameliorates lipid accumulation in non-alcoholic fatty liver disease through targeting NEU1.
    Hu Y; Ye H; Shi LX
    Eur Rev Med Pharmacol Sci; 2019 Nov; 23(22):10072-10082. PubMed ID: 31799678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hesperetin ameliorates hepatic oxidative stress and inflammation
    Li J; Wang T; Liu P; Yang F; Wang X; Zheng W; Sun W
    Food Funct; 2021 May; 12(9):3898-3918. PubMed ID: 33977953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.